Literature DB >> 26180248

Food Liking Enhances the Plasma Response of 2-Arachidonoylglycerol and of Pancreatic Polypeptide upon Modified Sham Feeding in Humans.

Ilario Mennella1, Rosalia Ferracane2, Francine Zucco2, Vincenzo Fogliano3, Paola Vitaglione4.   

Abstract

BACKGROUND: Food palatability increases food intake and may lead to overeating. The mechanisms behind this observation are still largely unknown.
OBJECTIVES: The aims of this study were the following: 1) to elucidate the plasma responses of endocannabinoids, N-acylethanolamines, and gastrointestinal peptides to a palatable (sweet), unpalatable (bitter), and sensory-acceptable (tasteless control) food, and 2) to verify whether some of these bioactive compounds can serve as plasma biomarkers of food liking in humans.
METHODS: Three puddings providing 60 kcal (35% from proteins, 62% from carbohydrates, and 3% from fats) but with different taste were developed. Twenty healthy subjects (11 women and 9 men; mean age 28 y and BMI 22.7 kg/m(2)), selected because they liked the puddings in the order sweet > control > bitter, participated in a randomized crossover study based on a modified sham feeding (MSF) protocol. Blood samples at baseline and every 5 min up to 20 min after the MSF were analyzed for gastrointestinal peptides, endocannabinoids, and N-acylethanolamines. Thirty minutes after the MSF, energy intake at an ad libitum breakfast was measured.
RESULTS: After the MSF, no response was observed in 7 of 9 gastrointestinal peptides measured. The plasma ghrelin concentration at 20 min after the sweet and bitter puddings was 25% lower than after the control pudding (P = 0.04), and the pancreatic polypeptide response after the sweet pudding was 23% greater than after the bitter pudding (P = 0.02). The plasma response of 2-arachidonoylglycerol after the sweet pudding was 37% and 15% higher than after the bitter (P < 0.001) and control (P = 0.03) puddings, respectively. Trends for greater responses of anandamide (P = 0.06), linoleoylethanolamide (P = 0.07), palmitoylethanolamide (P = 0.06), and oleoylethanolamide (P = 0.09) were found after the sweet pudding than after the bitter pudding. No differences in subsequent energy intake were recorded.
CONCLUSIONS: The data demonstrated that food palatability influenced some plasma endocannabinoid and N-acylethanolamine concentrations during the cephalic phase response and indicated that 2-arachidonoylglycerol and pancreatic polypeptide can be used as biomarkers of food liking in humans.
© 2015 American Society for Nutrition.

Entities:  

Keywords:  appetite control; bitter-tasting food; cephalic phase response; endocannabinoids; energy intake control; food palatability; gastrointestinal peptides

Mesh:

Substances:

Year:  2015        PMID: 26180248     DOI: 10.3945/jn.114.207704

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  10 in total

1.  Circadian Misalignment of the 24-hour Profile of Endocannabinoid 2-Arachidonoylglycerol (2-AG) in Obese Adults.

Authors:  Erin C Hanlon; Rachel Leproult; Kara L Stuhr; Elizabeth M Doncheck; Cecilia J Hillard; Eve Van Cauter
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

2.  Endocannabinoids in the Gut.

Authors:  Nicholas V DiPatrizio
Journal:  Cannabis Cannabinoid Res       Date:  2016-02-24

3.  Suppression of Oral Sweet Sensations during Consumption of Sweet Food in Humans: Effects on Gastric Emptying Rate, Glycemic Response, Appetite, Food Satisfaction and Desire for Basic Tastes.

Authors:  Naomi Kashima; Kanako Kimura; Natsumi Nishitani; Masako Yamaoka Endo; Yoshiyuki Fukuba; Hideaki Kashima
Journal:  Nutrients       Date:  2020-04-28       Impact factor: 5.717

4.  Exacting Responses: Lack of Endocrine Cephalic Phase Responses Upon Oro-Sensory Exposure.

Authors:  Marlou P Lasschuijt; Monica Mars; Cees de Graaf; Paul A M Smeets
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-13       Impact factor: 5.555

Review 5.  Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System-Implications for Health and Disease.

Authors:  Estefanía Moreno; Milena Cavic; Enric I Canela
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

Review 6.  (Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related Disorders.

Authors:  Jyoti Sihag; Vincenzo Di Marzo
Journal:  Lipids Health Dis       Date:  2022-01-14       Impact factor: 3.876

7.  Enhanced Recovery after Surgery Protocol Accelerates Recovery of Lumbar Disc Herniation among Elderly Patients Undergoing Discectomy via Promoting Gastrointestinal Function.

Authors:  Xiaohai Zuo; Linbang Wang; Longzhu He; Pei Li; Dandan Zhou; Yiping Yang
Journal:  Pain Res Manag       Date:  2021-11-22       Impact factor: 3.037

8.  Endocannabinoids, endocannabinoid-like molecules and their precursors in human small intestinal lumen and plasma: does diet affect them?

Authors:  Silvia Tagliamonte; Chris I R Gill; L Kirsty Pourshahidi; Mary M Slevin; Ruth K Price; Rosalia Ferracane; Roger Lawther; Gloria O'Connor; Paola Vitaglione
Journal:  Eur J Nutr       Date:  2020-10-26       Impact factor: 5.614

9.  Endocrine Cephalic Phase Responses to Food Cues: A Systematic Review.

Authors:  Marlou P Lasschuijt; Monica Mars; Cees de Graaf; Paul A M Smeets
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

10.  Mediterranean diet consumption affects the endocannabinoid system in overweight and obese subjects: possible links with gut microbiome, insulin resistance and inflammation.

Authors:  Silvia Tagliamonte; Manolo Laiola; Rosalia Ferracane; Marilena Vitale; Maria A Gallo; Victoria Meslier; Nicolas Pons; Danilo Ercolini; Paola Vitaglione
Journal:  Eur J Nutr       Date:  2021-03-24       Impact factor: 5.614

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.